Weight-loss drug showdown: Lilly vs Novo Nordisk amid supply crunch
Focus of debate is gradually turning from efficacy to availability in pharmacies
Focus of debate is gradually turning from efficacy to availability in pharmacies
US turns to China amid Indian pharmaceutical quality decline
-->